TIDMAGI

RNS Number : 8130R

AGI Therapeutics plc

09 November 2011

AGI Therapeutics plc ('AGI')

Holding in Company

AGI was notified on the 9(th) November 2011 that Paul Johnson has increased his shareholding to 2,720,615 shares representing 4.04% of AGI's Issued share capital.

Contact Information

AGI Therapeutics

   David G. Kelly, Chief Financial Officer   Tel: +353 1 449 3254

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLUKANRAWAARAA

AGI (LSE:AGI)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025 Click aqui para mais gráficos AGI.
AGI (LSE:AGI)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025 Click aqui para mais gráficos AGI.